126 related articles for article (PubMed ID: 3665357)
1. Increased arachidonic acid levels in phospholipids of human colonic mucosa in inflammatory bowel disease.
Pacheco S; Hillier K; Smith C
Clin Sci (Lond); 1987 Oct; 73(4):361-4. PubMed ID: 3665357
[TBL] [Abstract][Full Text] [Related]
2. Increased arachidonic acid composition of phospholipids in colonic mucosa from patients with active ulcerative colitis.
Nishida T; Miwa H; Shigematsu A; Yamamoto M; Iida M; Fujishima M
Gut; 1987 Aug; 28(8):1002-7. PubMed ID: 3117625
[TBL] [Abstract][Full Text] [Related]
3. Enhanced synthesis of leukotriene B4 by colonic mucosa in inflammatory bowel disease.
Sharon P; Stenson WF
Gastroenterology; 1984 Mar; 86(3):453-60. PubMed ID: 6319219
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical localization of vascular endothelial growth factor in colonic mucosa of patients with inflammatory bowel disease.
Griga T; May B; Pfisterer O; Müller KM; Brasch F
Hepatogastroenterology; 2002; 49(43):116-23. PubMed ID: 11941933
[TBL] [Abstract][Full Text] [Related]
5. Increased interleukin 8 expression in the colon mucosa of patients with inflammatory bowel disease.
Daig R; Andus T; Aschenbrenner E; Falk W; Schölmerich J; Gross V
Gut; 1996 Feb; 38(2):216-22. PubMed ID: 8801200
[TBL] [Abstract][Full Text] [Related]
6. Incorporation of fatty acids from fish oil and olive oil into colonic mucosal lipids and effects upon eicosanoid synthesis in inflammatory bowel disease.
Hillier K; Jewell R; Dorrell L; Smith CL
Gut; 1991 Oct; 32(10):1151-5. PubMed ID: 1955170
[TBL] [Abstract][Full Text] [Related]
7. Increased nitric oxide production and inducible nitric oxide synthase activity in colonic mucosa of patients with active ulcerative colitis and Crohn's disease.
Kimura H; Miura S; Shigematsu T; Ohkubo N; Tsuzuki Y; Kurose I; Higuchi H; Akiba Y; Hokari R; Hirokawa M; Serizawa H; Ishii H
Dig Dis Sci; 1997 May; 42(5):1047-54. PubMed ID: 9149061
[TBL] [Abstract][Full Text] [Related]
8. Different distribution of mast cells and macrophages in colonic mucosa of patients with collagenous colitis and inflammatory bowel disease.
Nishida Y; Murase K; Isomoto H; Furusu H; Mizuta Y; Riddell RH; Kohno S
Hepatogastroenterology; 2002; 49(45):678-82. PubMed ID: 12063968
[TBL] [Abstract][Full Text] [Related]
9. Analysis of direct tissue isoelectric focused protein profiles of resected intestinal mucosa and endoscopic biopsies from patients with inflammatory bowel disease.
Szewczuk MR; Depew WT
Clin Invest Med; 1992 Feb; 15(1):49-59. PubMed ID: 1374000
[TBL] [Abstract][Full Text] [Related]
10. Altered leukotriene B4 metabolism in colonic mucosa with inflammatory bowel disease.
Ikehata A; Hiwatashi N; Kinouchi Y; Yamazaki H; Ito K; Toyota T
Scand J Gastroenterol; 1995 Jan; 30(1):44-9. PubMed ID: 7701249
[TBL] [Abstract][Full Text] [Related]
11. Enhanced colonic nitric oxide generation and nitric oxide synthase activity in ulcerative colitis and Crohn's disease.
Rachmilewitz D; Stamler JS; Bachwich D; Karmeli F; Ackerman Z; Podolsky DK
Gut; 1995 May; 36(5):718-23. PubMed ID: 7541008
[TBL] [Abstract][Full Text] [Related]
12. Fatty acid composition of phospholipids in bile in man: promoting effect of deoxycholate on arachidonate.
van Berge Henegouwen GP; van der Werf SD; Ruben AT
Clin Chim Acta; 1987 May; 165(1):27-37. PubMed ID: 3111757
[TBL] [Abstract][Full Text] [Related]
13. Increased catabolism and decreased unsaturation of ganglioside in patients with inflammatory bowel disease.
Miklavcic JJ; Hart TD; Lees GM; Shoemaker GK; Schnabl KL; Larsen BM; Bathe OF; Thomson AB; Mazurak VC; Clandinin MT
World J Gastroenterol; 2015 Sep; 21(35):10080-90. PubMed ID: 26401073
[TBL] [Abstract][Full Text] [Related]
14. Increased production of matrix metalloproteinase-3 and tissue inhibitor of metalloproteinase-1 by inflamed mucosa in inflammatory bowel disease.
Louis E; Ribbens C; Godon A; Franchimont D; De Groote D; Hardy N; Boniver J; Belaiche J; Malaise M
Clin Exp Immunol; 2000 May; 120(2):241-6. PubMed ID: 10792371
[TBL] [Abstract][Full Text] [Related]
15. Phospholipid turnover in the inflamed intestinal mucosa: arachidonic acid-rich phosphatidyl/plasmenyl-ethanolamine in the mucosa in inflammatory bowel disease.
Morita H; Nakanishi K; Dohi T; Yasugi E; Oshima M
J Gastroenterol; 1999 Feb; 34(1):46-53. PubMed ID: 10204610
[TBL] [Abstract][Full Text] [Related]
16. Distribution and quantitation of gut neuropeptides in normal intestine and inflammatory bowel diseases.
Koch TR; Carney JA; Go VL
Dig Dis Sci; 1987 Apr; 32(4):369-76. PubMed ID: 2435473
[TBL] [Abstract][Full Text] [Related]
17. Plasma polyunsaturated fatty acid pattern in active inflammatory bowel disease.
Esteve-Comas M; Ramírez M; Fernández-Bañares F; Abad-Lacruz A; Gil A; Cabré E; González-Huix F; Moreno J; Humbert P; Guilera M
Gut; 1992 Oct; 33(10):1365-9. PubMed ID: 1446861
[TBL] [Abstract][Full Text] [Related]
18. Phospholipase A2 activating protein and idiopathic inflammatory bowel disease.
Peterson JW; Dickey WD; Saini SS; Gourley W; Klimpel GR; Chopra AK
Gut; 1996 Nov; 39(5):698-704. PubMed ID: 9014769
[TBL] [Abstract][Full Text] [Related]
19. Mucosal metabolism in ulcerative colitis and Crohn's disease.
Duffy MM; Regan MC; Ravichandran P; O'Keane C; Harrington MG; Fitzpatrick JM; O'Connell PR
Dis Colon Rectum; 1998 Nov; 41(11):1399-405. PubMed ID: 9823806
[TBL] [Abstract][Full Text] [Related]
20. [Eicosanoids in chronic inflammatory intestinal diseases].
Müller G
Z Gesamte Inn Med; 1987 Jan; 42(2):37-41. PubMed ID: 2883778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
